These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4509 related articles for article (PubMed ID: 31634899)

  • 41. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(2):838-44. PubMed ID: 27510639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cysteine preservation confers resistance to glutathione-depleted cells against ferroptosis via CDGSH iron sulphur domain-containing proteins (CISDs).
    Homma T; Kobayashi S; Fujii J
    Free Radic Res; 2020 Jun; 54(6):397-407. PubMed ID: 32605459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DHODH tangoing with GPX4 on the ferroptotic stage.
    Wang F; Min J
    Signal Transduct Target Ther; 2021 Jun; 6(1):244. PubMed ID: 34145214
    [No Abstract]   [Full Text] [Related]  

  • 44. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting lipid metabolism for ferroptotic cancer therapy.
    Luo M; Yan J; Hu X; Li H; Li H; Liu Q; Chen Y; Zou Z
    Apoptosis; 2023 Feb; 28(1-2):81-107. PubMed ID: 36399287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro.
    Homma T; Kobayashi S; Sato H; Fujii J
    Exp Cell Res; 2019 Nov; 384(1):111592. PubMed ID: 31479686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma.
    Liu MR; Shi C; Song QY; Kang MJ; Jiang X; Liu H; Pei DS
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37695069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CoQ10 targeted hippocampal ferroptosis in a status epilepticus rat model.
    Fikry H; Saleh LA; Mahmoud FA; Gawad SA; Abd-Alkhalek HA
    Cell Tissue Res; 2024 Jun; 396(3):371-397. PubMed ID: 38499882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
    Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
    Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
    Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
    Apoptosis; 2024 Aug; 29(7-8):1019-1037. PubMed ID: 38615304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron catalysis of lipid peroxidation in ferroptosis: Regulated enzymatic or random free radical reaction?
    Stoyanovsky DA; Tyurina YY; Shrivastava I; Bahar I; Tyurin VA; Protchenko O; Jadhav S; Bolevich SB; Kozlov AV; Vladimirov YA; Shvedova AA; Philpott CC; Bayir H; Kagan VE
    Free Radic Biol Med; 2019 Mar; 133():153-161. PubMed ID: 30217775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
    Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
    Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NMN recruits GSH to enhance GPX4-mediated ferroptosis defense in UV irradiation induced skin injury.
    Feng Z; Qin Y; Huo F; Jian Z; Li X; Geng J; Li Y; Wu J
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166287. PubMed ID: 34626772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A tangible method to assess native ferroptosis suppressor activity.
    Nakamura T; Ito J; Mourão ASD; Wahida A; Nakagawa K; Mishima E; Conrad M
    Cell Rep Methods; 2024 Mar; 4(3):100710. PubMed ID: 38401540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression.
    Tian RL; Wang TX; Huang ZX; Yang Z; Guan KL; Xiong Y; Wang P; Ye D
    J Mol Cell Biol; 2024 Sep; ():. PubMed ID: 39313331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the "Ferroptosis Storm".
    Xue P; Zhuang H; Shao S; Bai T; Zeng X; Yan S
    ACS Nano; 2024 Sep; 18(37):25795-25812. PubMed ID: 39226614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.
    Kim JW; Kim MJ; Han TH; Lee JY; Kim S; Kim H; Oh KJ; Kim WK; Han BS; Bae KH; Ban HS; Bae SH; Lee SC; Lee H; Lee EW
    Cell Death Dis; 2023 Aug; 14(8):567. PubMed ID: 37633973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
    Mishima E; Ito J; Wu Z; Nakamura T; Wahida A; Doll S; Tonnus W; Nepachalovich P; Eggenhofer E; Aldrovandi M; Henkelmann B; Yamada KI; Wanninger J; Zilka O; Sato E; Feederle R; Hass D; Maida A; Mourão ASD; Linkermann A; Geissler EK; Nakagawa K; Abe T; Fedorova M; Proneth B; Pratt DA; Conrad M
    Nature; 2022 Aug; 608(7924):778-783. PubMed ID: 35922516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 226.